How should sorafenib be used correctly? What is the dose?

Sorafenib is an oral multi-targeted kinase inhibitor mainly used to treat advanced liver cancer, kidney cancer and certain types of thyroid cancer. In order to ensure efficacy and safety, the doctor's prescription should be strictly followed when using it, and the dosage should be adjusted according to the patient's specific condition. When taking sorafenib, patients should swallow the tablet whole and avoid chewing or crushing the drug to ensure the integrity of the drug effect and the safe release of the drug.

The dosage of sorafenib varies depending on the type of disease. Generally, the recommended dose of sorafenib is 400 mg twice daily, for a total dose of 800 mg daily. For patients with liver cancer, it is generally recommended to continue taking medication until disease progression or intolerable side effects occur. If obvious adverse reactions occur during use, the doctor may adjust the dose appropriately based on the patient's response. It should be noted that sorafenib should be taken with food to reduce irritation to the gastrointestinal tract.

There are several key points to pay special attention to when using sorafenib. First of all, sorafenib may cause some serious side effects, such as high blood pressure, rash, hand-foot skin reaction, etc. Therefore, patients should monitor their blood pressure regularly during use and promptly report any symptoms of skin discomfort or other physical discomfort. In addition, sorafenib has a certain impact on liver and kidney function. Therefore, patients need to have liver and kidney function evaluated before starting treatment, and liver and kidney function also need to be monitored regularly during treatment.

Sorafenib is generally not recommended for pregnant and breastfeeding women because of the potential harm to the fetus or infant. In addition, patients with severe hepatic and renal insufficiency or allergies to sorafenib components should avoid using this drug. Before starting treatment, patients should inform their doctor if they have any other medical conditions or medications they are taking to avoid drug-drug interactions. In general, the use of sorafenib should be based on an individualized treatment plan to ensure that patients are adequately monitored and adjusted during treatment.

Reference materials:https://www.nexavar.com/

xa0